Share

August 2015; 2 (4) Clinical/Scientific NotesOpen Access

Transient anti-NMDAR encephalitis in a newborn infant due to transplacental transmission

Michelle Hilderink, Maarten J. Titulaer, Marco W.J. Schreurs, Koos Keizer, Jan Erik H. Bunt
First published June 18, 2015, DOI: https://doi.org/10.1212/NXI.0000000000000126
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
707

Share

Article Information

vol. 2 no. 4 e126
DOI: 
https://doi.org/10.1212/NXI.0000000000000126
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Online ISSN: 
2332-7812
History: 
  • Received March 25, 2015
  • Accepted in final form May 14, 2015
  • First Published June 18, 2015.
Copyright & Usage: 
© 2015 American Academy of Neurology This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially.

Author Disclosures

    1. Michelle Hilderink, MD,
    2. Maarten J. Titulaer, MD, PhD,
    3. Marco W.J. Schreurs, PhD,
    4. Koos Keizer, MD, PhD and
    5. Jan Erik H. Bunt, MD, PhD
  1. Michelle Hilderink, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Maarten J. Titulaer, MD, PhD,
    3. Scientific Advisory Boards:

    1. (1) Serve on the scientific advisory board of MedImmune LLC.

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. (1) Sun Pharma, travel grant for lecturing in India

    Editorial Boards:

    1. (1) Neurology: Neuroimmunology & Neuroinflammation, since June 2014

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) supported by the Netherlands Organisation for Scientific Research (NWO, Veni incentive)

    Research Support, Academic Entities:

    1. (1) Currently supported by an ErasmusMC fellowship

    Research Support, Foundations and Societies:

    1. (1) supported by the Dutch Epilepsy Foundations, projectnumber 14-19.

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Marco W.J. Schreurs, PhD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Koos Keizer, MD, PhD and
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Jan Erik H. Bunt, MD, PhD
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Pediatrics (M.H., J.E.H.B.) and Department of Neurology (K.K.), Catharina Hospital, Eindhoven, the Netherlands; Department of Neurology (M.J.T.) and Department of Immunology (M.W.J.S.), Erasmus Medical Center, Rotterdam, the Netherlands; and Department of Pediatrics (J.E.H.B.), Elisabeth-TweeSteden, Tilburg, the Netherlands.
  1. Correspondence to Dr. Hilderink: michelle.hilderink{at}catharinaziekenhuis.nl
View Full Text

Article usage

Article usage: June 2015 to August 2023

AbstractFullPdfSource
Jun 201598407Highwire
Jul 20155524143Highwire
Jul 201503412pmc
Aug 20158811517Highwire
Aug 20150112pmc
Sep 201517629Highwire
Sep 20150154pmc
Oct 2015157116Highwire
Oct 20150141pmc
Nov 20151273Highwire
Nov 201501410pmc
Dec 20151033Highwire
Dec 2015055pmc
Jan 20161552Highwire
Jan 20160176pmc
Feb 20161071Highwire
Feb 2016074pmc
Mar 20163882Highwire
Mar 20160368pmc
Apr 2016491Highwire
Apr 2016083pmc
May 2016780Highwire
May 2016074pmc
Jun 2016201018Highwire
Jun 2016064pmc
Jul 20162081Highwire
Jul 20160122pmc
Aug 20161670Highwire
Aug 2016062pmc
Sep 20161381Highwire
Sep 2016040pmc
Oct 20162065Highwire
Oct 2016093pmc
Nov 2016622Highwire
Nov 2016040pmc
Dec 2016422Highwire
Dec 20160131pmc
Jan 2017731Highwire
Jan 20170124pmc
Feb 2017811Highwire
Feb 2017092pmc
Mar 20171564Highwire
Mar 20170150pmc
Apr 2017671Highwire
Apr 201711010pmc
May 2017321Highwire
May 2017587pmc
Jun 2017933Highwire
Jun 2017055pmc
Jul 2017430Highwire
Jul 2017588pmc
Aug 20171136Highwire
Aug 201741311pmc
Sep 2017511Highwire
Sep 201721011pmc
Oct 2017220Highwire
Oct 2017287pmc
Nov 2017431Highwire
Nov 201731313pmc
Dec 2017371Highwire
Jan 2018074Highwire
Feb 20180102Highwire
Mar 20181112Highwire
Apr 20181111Highwire
Apr 2018376pmc
May 20180172Highwire
Jun 20181162Highwire
Jun 2018055pmc
Jul 20183306Highwire
Aug 20181182Highwire
Aug 201831212pmc
Sep 2018061Highwire
Oct 20181192Highwire
Nov 201842210Highwire
Dec 20180210Highwire
Jan 20193223Highwire
Feb 20193212Highwire
Mar 20192137Highwire
Apr 2019133Highwire
May 20195147Highwire
Jun 20192165Highwire
Jul 20192216Highwire
Aug 20192156Highwire
Sep 2019173Highwire
Oct 20190102Highwire
Nov 20190167Highwire
Dec 20192259Highwire
Jan 2020053Highwire
Feb 20203368Highwire
Mar 20200106Highwire
Apr 2020181Highwire
May 20200123Highwire
Jun 20200127Highwire
Jul 20202162Highwire
Aug 2020043Highwire
Sep 20203256Highwire
Oct 20201264Highwire
Nov 20201127Highwire
Dec 20202126Highwire
Jan 20213204Highwire
Feb 2021061Highwire
Mar 2021194Highwire
Apr 20211167Highwire
May 202101810Highwire
Jun 20212142Highwire
Jul 20213108Highwire
Aug 20211214Highwire
Sep 2021176Highwire
Oct 202114130Highwire
Nov 202101612Highwire
Dec 202112410Highwire
Jan 202241410Highwire
Feb 2022182Highwire
Mar 20223286Highwire
Apr 2022114Highwire
May 202201711Highwire
Jun 20220133Highwire
Jul 2022191Highwire
Aug 20220218Highwire
Sep 202202511Highwire
Oct 20223269Highwire
Nov 202206115Highwire
Dec 202202611Highwire
Jan 20231316Highwire
Feb 20230234Highwire
Mar 2023263Highwire
Apr 2023098Highwire
May 2023075Highwire
Jun 20231113Highwire
Jul 2023167Highwire
Aug 2023067Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me

Recommended articles